Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia
- 15 August 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (16) , 4768-4772
- https://doi.org/10.1016/j.bmcl.2009.06.054
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Low HDL Cholesterol LevelsNew England Journal of Medicine, 2005
- Pyrazole Derivatives as Partial Agonists for the Nicotinic Acid ReceptorJournal of Medicinal Chemistry, 2003
- High density lipoproteins (HDLs) and atherosclerosis; the unanswered questionsAtherosclerosis, 2003
- Molecular identification of nicotinic acid receptorBiochemical and Biophysical Research Communications, 2003
- Molecular Identification of High and Low Affinity Receptors for Nicotinic AcidJournal of Biological Chemistry, 2003
- PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effectNature Medicine, 2003
- Evaluating niacin in its various formsThe American Journal of Cardiology, 2000
- Niacin-Induced Hepatitis: A Potential Side Effect With Low-Dose Time-Release NiacinMayo Clinic Proceedings, 1991
- Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratioThe American Journal of Cardiology, 1989
- Studies on Hypolipidemic Agents. II. Synthesis and Pharmacological Properties of Alkylpyrazole DerivativesCHEMICAL & PHARMACEUTICAL BULLETIN, 1984